InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Demetri George, 董事. Director active across 1 company, notably Blueprint Medicines Corp. Cumulatively, 2 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €702. History available since 2 June 2021. The latest transaction was disclosed on 13 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Demetri George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
10 股@ US$82.66100.0% 占其流量Common StockSEC:0001415889-22-007129:0
标准退出：2021年10月11日 (T+90)
2,250 股0Common StockSEC:0001179110-21-006418:0
2 条申报中的 2 条
About Demetri George
Demetri George is a Board Member at Blueprint Medicines Corp. He plays a vital role in the governance of the company, providing strategic advice and overseeing development initiatives.
